Harvard Bioscience Inc (HBIO) stock
HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3017% above fair value
$9.00−0.08 (-0.88%)
Close on Nov 18, 2026Market cap $40.97MP/E –Yield –
Harvard Bioscience ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2012 it was $12.04M, down 5.5% from the year before.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $12.04M | -5.5% |
| FY2011 | Dec 31, 2011 | $12.73M | -9.9% |
| FY2010 | Dec 31, 2010 | $14.14M | – |
See a number that looks wrong?